Analyst Ratings for Axsome Therapeutics (AXSM)
AXSM Rating Summary
AXSM Price Target Summary
- Highest: $380.00 (Jefferies)
- Lowest: $150.00 (Leerink)
- Average: $268.32
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$268.32 (+70.7%)
* Over Last 12-Mos
Rating Score: 9.6 / 10
Percentile Rank: 91%
Avg. $ Target:
$268.32 (+70.7%)
* Over Last 12-Mos
Rating Score: 9.6 / 10
Percentile Rank: 91%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/23/2026 | Truist Securities | Srikripa Devarakonda | New Coverage | Buy (N/A) |
285.00 (N/A) |
203.10 (157.14) |
-22.63% | Details |
| 7/20/2026 | BMO Capital | Malcolm Hoffman | New Coverage | Outperform (N/A) |
310.00 (N/A) |
230.00 (157.14) |
-31.68% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
